PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2017

Formononetin protects against acetaminophen-induced hepatotoxicity through enhanced NRF2 activity.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 28234915 ↗2017Reported benefit

Formononetin protects against acetaminophen-induced hepatotoxicity through enhanced NRF2 activity.

MouseChemical/toxinBALB/cMalen = 4-6 mice per group across four groups; 4 per group for Nrf2…Oral gavage (formononetin dissolved in 0.5% CMC-Na)50 mg/kg and 100 mg/kgPre-treatment, given daily for seven consecutive days before the acetaminophen…

Model: Acetaminophen-induced acute liver injury by a single intraperitoneal dose of 300 mg/kg acetaminophen dissolved in PBS pH 7.4

Formononetin at 100 mg/kg reduced hepatic malondialdehyde from 1.97 plus or minus 0.27 to 0.55 plus or minus 0.14 nmol/mg protein, ALT from 955.80 plus or minus 209.40 to 46.90 plus or minus 20.40 IU/L and AST from 1533.80 plus or minus 244.80 to 56.70 plus or minus 28.80 IU/L (all p < 0.001), rais…

Extraction: extract · Supplied extraction confidence: 0.93. Machine-extracted fields require source verification.